Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-26

FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for oxybutynin chloride from Upsher-Smith Laboratories, likely updating labeling or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

SUPPL AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)